Altrius Capital Management Inc Has $7.31 Million Position in Roche Holding AG (OTCMKTS:RHHBY)

Altrius Capital Management Inc lowered its position in Roche Holding AG (OTCMKTS:RHHBY) by 18.7% in the third quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 182,845 shares of the company’s stock after selling 41,959 shares during the quarter. Roche makes up about 1.8% of Altrius Capital Management Inc’s investment portfolio, making the stock its 21st largest holding. Altrius Capital Management Inc’s holdings in Roche were worth $7,305,000 at the end of the most recent reporting period.

A number of other hedge funds also recently modified their holdings of the stock. SVB Wealth LLC lifted its stake in shares of Roche by 2.6% during the 1st quarter. SVB Wealth LLC now owns 16,646 shares of the company’s stock worth $531,000 after buying an additional 426 shares during the last quarter. Confluence Investment Management LLC lifted its stake in shares of Roche by 3.7% during the 2nd quarter. Confluence Investment Management LLC now owns 12,922 shares of the company’s stock worth $448,000 after buying an additional 459 shares during the last quarter. Norman Fields Gottscho Capital Management LLC lifted its stake in shares of Roche by 2.3% during the 2nd quarter. Norman Fields Gottscho Capital Management LLC now owns 24,650 shares of the company’s stock worth $858,000 after buying an additional 550 shares during the last quarter. Archer Investment Corp lifted its stake in shares of Roche by 10.6% during the 2nd quarter. Archer Investment Corp now owns 6,810 shares of the company’s stock worth $236,000 after buying an additional 652 shares during the last quarter. Finally, Hancock Whitney Corp raised its stake in Roche by 2.4% in the 1st quarter. Hancock Whitney Corp now owns 28,995 shares of the company’s stock worth $926,000 after purchasing an additional 678 shares in the last quarter.

Wall Street Analyst Weigh In

Several analysts have weighed in on the stock. Bank of America upgraded shares of Roche from a “neutral” rating to a “buy” rating in a research note on Friday, September 13th. Deutsche Bank Aktiengesellschaft cut shares of Roche from a “hold” rating to a “sell” rating in a research note on Friday, September 13th. Three research analysts have rated the stock with a sell rating, one has issued a hold rating and one has assigned a buy rating to the stock. According to MarketBeat, Roche presently has an average rating of “Hold”.

Roche Price Performance

RHHBY stock traded down $0.88 during mid-day trading on Friday, hitting $36.14. The stock had a trading volume of 1,148,126 shares, compared to its average volume of 1,155,110. Roche Holding AG has a 52 week low of $29.20 and a 52 week high of $42.43. The firm has a fifty day simple moving average of $39.04 and a 200 day simple moving average of $37.03.

About Roche

Roche Holding AG engages in the pharmaceuticals and diagnostics businesses in Europe, North America, Latin America, Asia, Africa, Australia, and Oceania. The company offers pharmaceutical products in the therapeutic areas of anemia, blood and solid tumors, dermatology, hemophilia, inflammatory and autoimmune, neurological disorders, ophthalmology, respiratory disorders, and transplantation.